Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma

By                              

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2005-2012

Spandidos Publications

Access to resources Recommend Favorite

Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy

By Yang Sen   Yan Hong-Li   Tao Qi-Fei   Yuan Sheng-Xian   Tang Guan-Nan   Yang Yuan   Wang Li-Li   Zhang Yi-Liang   Sun Shu-Han   Zhou Wei-Ping  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 109-116

Springer Publishing Company

Access to resources Recommend Favorite

TNF-α -863 polymorphisms and the risk of hepatocellular carcinoma

By          

Experimental and Therapeutic Medicine, Vol. 3, Iss. 3, 2012-01 ,pp. : 513-518

Spandidos Publications

Access to resources Recommend Favorite

Role of ERCC5 polymorphism in risk of hepatocellular carcinoma

By        

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 911-914

Spandidos Publications

Access to resources Recommend Favorite

Clinical characteristics of hepatocellular carcinoma in elderly patients

By                  

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 851-854

Spandidos Publications

Access to resources Recommend Favorite